Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO–(BUSINESS WIRE)–Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on September 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to 20 new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 69,300 shares of its common stock. These inducement RSUs are subject to the … [Read more…]

enGene Reports Third Quarter 2025 Financial Results and Provides Business Update

Achieved target enrollment milestone for LEGEND trial pivotal cohort in high-risk BCG unresponsive NMIBC with carcinoma in situ LEGEND’s pivotal cohort data update planned for 4Q 2025 Detalimogene granted Regenerative Medicine Advanced Therapy (RMAT) designation by FDA Biologic License Application (BLA) submission planned for 2H 2026 Cash and marketable securities of $224.9 million expected to … [Read more…]

Myriad Systems Launches Myriad Motion to Revolutionize EHR Onboarding

System empowers providers to launch a fully integrated practice management solution, enhancing efficiency and patient care WHITE PLAINS, N.Y.–(BUSINESS WIRE)–#AIinHealthcare—Myriad Systems, a leader in healthcare practice management, announces Myriad Motion, a new AI-powered automated onboarding tool designed to simplify the complex process of switching to a new electronic health record (EHR) and all-in-one practice management … [Read more…]

Momcozy Honored at Kind+Jugend 2025 for Innovation in Maternal Care

COLOGNE, Germany–(BUSINESS WIRE)–Momcozy, a global leader in maternal care and a pioneer of the Mom-First philosophy, announced at Kind+Jugend that its Ergonest Maternity Support Belt has won the 2025 Kind+Jugend Innovation Award. At the same time, the company unveiled its “Love & Loneliness” study on postpartum mental health and pledged €5,000 to support the Frauenmilchbank … [Read more…]

Casey Graves Joins ConcertAI as General Manager, Clinical Solutions

CAMBRIDGE, Mass.–(BUSINESS WIRE)–ConcertAI, a leading provider of multi-modal data and agentic AI solutions for life sciences and healthcare, today announced the appointment of Casey Graves as general manager of Clinical Solutions. In this pivotal role, Graves will drive growth and innovation in real-world data (RWD) and AI solutions for oncology research and clinical care, accelerating … [Read more…]

ENHERTU® Type II Variation Application Validated in the EU for Previously Treated Patients with HER2 Positive Metastatic Solid Tumors

Submission based on three phase 2 trials where Daiichi Sankyo and AstraZeneca’s ENHERTU showed clinically meaningful responses across a broad range of tumors If approved, ENHERTU would become the first HER2 directed medicine and antibody drug conjugate to receive a tumor agnostic indication in the EU TOKYO & MUNICH–(BUSINESS WIRE)–The European Medicines Agency (EMA) has … [Read more…]

EADV 2025: Galderma Reinforces Leadership in Dermatology With Latest Advances in Sensitive Skin and Itch

Galderma will present a wealth of data including new findings showing the impact of modern living on sensitive skin and insights from the largest global survey conducted on the condition Late-breaking data on Nemluvio’s® (nemolizumab) mode of action in atopic dermatitis (AD) and long-term safety and efficacy data in prurigo nodularis (PN) and moderate-to-severe AD … [Read more…]

Contrast Enhanced Ultrasound Shows 100% Sensitivity and Specificity for Finding Residual or Recurrent Kidney Tumors

CHICAGO–(BUSINESS WIRE)–#CEUS–Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding residual or recurrent kidney tumors in patients who have had a kidney-sparing procedure, according to a new study announced today at the 39th annual International Bubble Conference in Chicago. The study … [Read more…]

PurpleLab Expands the Healthcare Advertising Ecosystem with Consecutive Strategic Partnerships

The healthcare analytics company partnered with Experian, DeepIntent, InsightsRx, and Comscore to deliver scale, precision, privacy-conscious targeting, and real-time measurement for pharmaceutical advertisers. PHILADELPHIA–(BUSINESS WIRE)–PurpleLab®, the healthcare analytics company powering evidence-based decisions across life sciences, has announced a series of major partnerships with Experian, DeepIntent, InsightsRx, and Comscore. Together, these collaborations allow advertisers to use … [Read more…]

Contrast Enhanced Ultrasound Imaging Helps Streamline Hospital Workflows, Survey Says

CHICAGO–(BUSINESS WIRE)–#CEUS–Contrast enhanced ultrasound (CEUS) often streamlines hospital workflows while providing safe, accurate and cost-effective diagnostic imaging, according to responses to a survey described today at a medical conference in Chicago. Survey respondents said that CEUS offers reliable diagnostic information in real time using ultrasound systems that are readily available in many medical centers – … [Read more…]